SpringWorks Therapeutics, Inc. (SWTX) Financials

SWTX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 725.8 million 99.6 million
2023-09-30 467.7 million 72.8 million
2023-06-30 517.3 million 65.9 million
2023-03-31 569.2 million 62.3 million

SWTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -60.4 million 25.1 million
2023-09-30 -54.1 million 23.1 million
2023-06-30 -50.9 million 23.0 million
2023-03-31 -64.8 million 23.4 million

SWTX Net Income

No data available :(

SWTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 479.2 million - 7.1 million
2023-09-30 422.4 million - 7.3 million
2023-06-30 476.7 million - 7.6 million
2023-03-31 528.1 million - 7.1 million

SWTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 73.5 million
2023-09-30 62.5 million
2023-06-30 62.5 million
2023-03-31 62.3 million

SWTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 2.3 million 43.7 million 59.8 million -
2023-09-30 3.6 million 37.5 million 46.5 million -
2023-06-30 3.1 million 35.9 million 47.0 million -
2023-03-31 3.0 million 33.5 million 44.2 million -

SWTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 5.4 million 960000
2023-09-30 5.6 million 933000
2023-06-30 5.8 million 833000
2023-03-31 5.6 million 539000

SWTX

Price: $44.48

52 week price:
18.00
53.92

Earnings Per Share: -5.15 USD

P/E Ratio: -9.87

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 625779

Market Capitalization: 3.3 billion

Links: